Test Price
2,800 AED✅ Home Collection Available
UCHL1 Gene (PARK5) Parkinson's Disease Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Diagnostic Sensitivity: 99.9% via Next-Generation Sequencing (NGS) in an ISO 9001:2015 certified laboratory.
- Mobile Phlebotomy: VIP home collection with temperature-controlled cold-chain logistics, available daily from 8 AM to 11 PM.
- Post-Test Support: Telephonic clinical guidance and genetic counselling included with every result.
- Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731 before testing.
Test Overview & Methodology
This NGS test analyses the entire coding region and splice junctions of the UCHL1 gene (PARK5) to identify pathogenic variants associated with autosomal dominant Parkinson's disease. Early risk stratification enables personalised management and informed family planning. The test is performed in compliance with UAE genetic testing regulations and international clinical standards.
| Feature | Our Test: UCHL1 PARK5 NGS | Closest Alternative (Parkin Gene Single-Site Analysis) |
|---|---|---|
| Methodology | Full UCHL1 gene NGS (exons + splice sites) | PCR-based targeted mutation analysis (limited coverage) |
| Diagnostic Sensitivity | 99.9% (ISO 9001:2015 certified lab) | ~85% (may miss rare or novel variants) |
| Turnaround Time | 3–4 weeks with genetic counselling | 6–8 weeks typical in UAE |
| Compliance | UAE PDPL, Federal Law No. 2 of 2019, DHA regulations | Variable; often lacks standardised consent framework |
| Post-Test Support | Telephonic clinical guidance included | Not standard |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I stress that a UCHL1 variant indicates elevated lifetime risk, not a definitive diagnosis. Results must be integrated with a full neurological examination and detailed family history, interpreted under the guidance of a DHA-licensed genetic counselor. Patients should never discontinue prescribed Parkinson's medications without prior consultation with their treating physician.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Safety
Do not stop, adjust, or alter any prescribed Parkinson's medications without explicit approval from your treating neurologist. Abrupt discontinuation may lead to severe symptom rebound or neuroleptic malignant syndrome. Always discuss genetic test results with your doctor before making any therapeutic changes.
Exclusion Criteria & Red Flags
- Minors below 18 years require parental/legal guardian consent in accordance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Not recommended for asymptomatic individuals without a family history of early-onset Parkinson's or a confirmed UCHL1 mutation in a first-degree relative.
- If you are experiencing acute neurological deterioration, sudden falls, confusion, or new-onset hallucinations, seek emergency medical care immediately — do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the purpose of the UCHL1 genetic test for Parkinson's?
This NGS test identifies pathogenic mutations in the UCHL1 gene that are linked to autosomal dominant Parkinson's disease, enabling early risk assessment and personalised management planning. It is a predictive tool, not a standalone diagnostic.
2. How is the sample collected and what are the requirements?
A simple peripheral blood sample is collected via our VIP mobile phlebotomy service using cold-chain logistics compliant with ISO 9001:2015. The service is available daily from 8 AM to 11 PM. Alternatively, you may visit our Dubai Healthcare City facility for in-person collection.
3. Will my insurance cover this test and how long do results take?
We verify insurance coverage directly via WhatsApp (+971 54 548 8731) prior to testing. The turnaround time is 3–4 weeks, and results are accompanied by a telephonic genetic counselling session to review findings and next steps.
UAE Regulatory & Data Privacy Adherence
Data Privacy: This test fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). All genetic data is encrypted, stored securely, and never shared without explicit patient consent.
Health Information Protection: Adherence to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields ensures that all electronic health records and test results are handled with the highest security standards.
Clinical Governance: Patient safety and consent processes are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility (License No. 1143) operates under the regulatory oversight of the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | UCHL1 (PARK5) Gene Full Sequencing – Parkinson's Disease Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (including genetic counselling report) |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8AM–11PM |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene analysis including coding exons and flanking splice sites |
| ICD-10-CM Code | G20 (Parkinson's disease) |
| LOINC Code | 93196-7 (UCHL1 gene mutation analysis in blood) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians